SCHEMBL1743735

SCHEMBL1743735

COCc1nc(NC(=O)O)sc1Br

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
HSD17B10 Q99714 3/20 0.39
TSHR P16473 2/20 0.39
HPGD P15428 1/20 0.39
GAA P10253 1/20 0.38
MAPK1 P28482 1/20 0.37
RAB9A P51151 4/20 0.37
NPC1 O15118 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
MAPT P10636 2/20 0.35
HTT P42858 1/20 0.35
ALOX5 P09917 1/20 0.35
TP53 P04637 1/20 0.35
POLB P06746 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4294136 0.88 ALDH1A1 (0.42) ALDH1A1HSD17B10TSHRHPGDGAA
SCHEMBL1741900 0.81 LCK (0.45) TSHR
SCHEMBL4877872 0.76 LMNA (0.48) ALDH1A1TSHRGAARAB9ANPC1
SCHEMBL16757197 0.74 RAB9A (0.44) ALDH1A1HPGDGAARAB9ANPC1
SCHEMBL4969363 0.74 PIK3CG (0.43) ALDH1A1HPGDGAARAB9ANPC1
SCHEMBL4292228 0.74 ALDH1A1 (0.44) ALDH1A1HSD17B10HPGDGAARAB9A
SCHEMBL4301594 0.73 MAPT (0.37) ALDH1A1HSD17B10TSHRHPGDGAA
SCHEMBL4291781 0.71 ALDH1A1 (0.48) ALDH1A1HSD17B10TSHRHPGDGAA
SCHEMBL12002438 0.69 SMN1; SMN2 (0.69) ALDH1A1HSD17B10TSHRHPGDGAA
SCHEMBL27760073 0.68 ALDH1A1 (0.51) ALDH1A1TSHRHPGDGAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387570-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE Amgen, Inc (US) 2011-11-23 EP disclosed
US-20110263647-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2011-10-27 US disclosed
WO-2010083246-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263647-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE TFEB, PCK2, JAK2 ALDH1A1 2488/4885HSD17B10 1304/4885TSHR 1392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.